Elisa FICARRA

Elisa FICARRA

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2015 in Cancer Cell
Verified
Journal Article
Closed access
RCRamona Crescenzo
Ramona Crescenzo
FAFrancesco Abate
Francesco Abate
ELElena Lasorsa
Elena Lasorsa
FTFabrizio Tabbo’
Fabrizio Tabbo’
MGMarcello Gaudiano
Marcello Gaudiano
GIGiorgio Inghirami
Giorgio Inghirami

31 May 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
CIClaudio Isella
Claudio Isella
FBFrancesco Brundu
Francesco Brundu
SBSara E. Bellomo
Sara E. Bellomo
FGFrancesco Galimi
Francesco Galimi
EZEugenia Zanella
Eugenia Zanella
ABAndrea Bertotti
Andrea Bertotti
Stromal content heavily impacts the transcriptional classification of colorectal cancer (CRC), with clinical and biological implications. Lineage-dependent stromal transcriptional components could therefore dominate over more subtle expression traits inherent to cancer cells. Since in patient-derived xenografts (PDXs) stromal cells of the human tumour are substituted by murine counterparts, here we deploy human-specific expression profiling of CRC PDXs to assess cancer-cell intrinsic transcriptional features. Through this approach, we identify five CRC intrinsic subtypes (CRIS) endowed with distinctive molecular, functional and phenotypic peculiarities: (i) CRIS-A: mucinous, glycolytic, enriched for microsatellite instability or KRAS mutations; (ii) CRIS-B: TGF-β pathway activity, epithelial–mesenchymal transition, poor prognosis; (iii) CRIS-C: elevated EGFR signalling, sensitivity to EGFR inhibitors; (iv) CRIS-D: WNT activation, IGF2 gene overexpression and amplification; and (v) CRIS-E: Paneth cell-like phenotype, TP53 mutations. CRIS subtypes successfully categorize independent sets of primary and metastatic CRCs, with limited overlap on existing transcriptional classes and unprecedented predictive and prognostic performances.

1 October 2010 in Computer Methods and Programs in Biomedicine
Verified
Journal Article
Closed access
SCSanta Di Cataldo
Santa Di Cataldo
EFElisa FICARRA
Elisa FICARRA
AAA. Acquaviva
A. Acquaviva
EME. Macii
E. Macii

17 November 2015 in Nature Communications
Verified
Journal Article
Open access
PDF file
LCLaura Cantini
Laura Cantini
CIClaudio Isella
Claudio Isella
CPConsalvo Petti
Consalvo Petti
GPGabriele Picco
Gabriele Picco
SCSimone Chiola
Simone Chiola
EMEnzo Medico
Enzo Medico
Colorectal cancer (CRC) transcriptional subtypes have been recently identified by gene expression profiling. Here we describe an analytical pipeline, microRNA master regulator analysis (MMRA), developed to search for microRNAs potentially driving CRC subtypes. Starting from a microRNA–mRNA tumour expression data set, MMRA identifies candidate regulator microRNAs by assessing their subtype-specific expression, target enrichment in subtype mRNA signatures and network analysis-based contribution to subtype gene expression. When applied to a CRC data set of 450 samples, assigned to subtypes by 3 different transcriptional classifiers, MMRA identifies 24 candidate microRNAs, in most cases downregulated in the stem/serrated/mesenchymal (SSM) poor prognosis subtype. Functional validation in CRC cell lines confirms downregulation of the SSM subtype by miR-194, miR-200b, miR-203 and miR-429, which share target genes and pathways mediating this effect. These results show that, by combining statistical tests, target prediction and network analysis, MMRA effectively identifies microRNAs functionally associated to cancer subtypes.

4 September 2014 in BMC Systems Biology
Verified
Journal Article
Open access
PDF file
FAFrancesco Abate
Francesco Abate
SZSakellarios Zairis
Sakellarios Zairis
EFElisa FICARRA
Elisa FICARRA
Andrea AcquavivaAndrea Acquaviva
Andrea Acquaviva
CWChris H Wiggins
Chris H Wiggins
RRRaul Rabadan
Raul Rabadan
The extraordinary success of imatinib in the treatment of BCR-ABL1 associated cancers underscores the need to identify novel functional gene fusions in cancer. RNA sequencing offers a genome-wide view of expressed transcripts, uncovering biologically functional gene fusions. Although several bioinformatics tools are already available for the detection of putative fusion transcripts, candidate event lists are plagued with non-functional read-through events, reverse transcriptase template switching events, incorrect mapping, and other systematic errors. Such lists lack any indication of oncogenic relevance, and they are too large for exhaustive experimental validation.

9 December 2016 in Computational and Structural Biotechnology Journal
Verified
Journal Article
Open access
SCSanta Di Cataldo
Santa Di Cataldo
EFElisa FICARRA
Elisa FICARRA
Texture analysis is a major task in many areas of computer vision and pattern recognition, including biological imaging. Indeed, visual textures can be exploited to distinguish specific tissues or cells in a biological sample, to highlight chemical reactions between molecules, as well as to detect subcellular patterns that can be evidence of certain pathologies. This makes automated texture analysis fundamental in many applications of biomedicine, such as the accurate detection and grading of multiple types of cancer, the differential diagnosis of autoimmune diseases, or the study of physiological processes. Due to their specific characteristics and challenges, the design of texture analysis systems for biological images has attracted ever-growing attention in the last few years. In this paper, we perform a critical review of this important topic. First, we provide a general definition of texture analysis and discuss its role in the context of bioimaging, with examples of applications from the recent literature. Then, we review the main approaches to automated texture analysis, with special attention to the methods of feature extraction and encoding that can be successfully applied to microscopy images of cells or tissues. Our aim is to provide an overview of the state of the art, as well as a glimpse into the latest and future trends of research in this area.